Skip to main content

SRPT Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Sarepta Therapeutics Inc. News

The Sarepta Therapeutics Pipeline No One is Talking About

Gene therapy and gene editing get all the glory, but investors shouldn't overlook an emerging group of tools.

Why Wall Street Doubts This Biotech Penny Stock Will Be Delisted

The share price dipped below $1 -- into penny stock territory -- but analysts are optimistic they'll recover.

Barclays Lists Halliburton, Dick's, Ally as 2022 Earnings Winners

Barclays made a list of 35 stocks with overweight ratings that it expects to benefit from strong earnings next year.

Sarepta Higher After Progress With Muscular Dystrophy Drug Trial

Sarepta's trial supports its drug's 'potentially differentiated profile' to treat Duchenne muscular dystrophy, the company said. The stock is higher.

Boeing, Micron, Pfizer, Sarepta - Friday's Premarket Movers

Stocks moving in premarket trading Friday include Boeing, Micron, Pfizer, Sarepta and Moderna.

Breaking News

Elon Musk Says Only Two Things Could Make Him Leave Tesla

Tesla CEO Musk discusses succession plans and Twitter with shareholders.

Caesars Inches Closer to Huge Las Vegas Strip Move

The company has made clear what it plans on the Las Vegas Strip, but it has a fast-approaching deadline.

Elon Musk Has Bad News About Tesla's Cybertruck

Long-delayed futuristic looking electric vehicle will be in production by the middle of 2023